Stay in the know
We’ll send you the latest insights and briefings tailored to your needs
A total of 15,384,615 ordinary shares are being offered, of which 3,846,153 shares are being offered by Marex and 11,538,462 shares are being offered by certain selling shareholders, priced at $19.00 per share. This values Marex at $1.35 billion.
The offering is expected to close on April 29, 2024, subject to customary closing conditions.
The Herbert Smith Freehills team was led by head of US securities Tom O'Neill, managing partner for Corporate Mike Flockhart and of counsel Thomas Vaughan, supported by associates Gaelen Perrone and Zarko Perovic. The wider team included partners Paul Ellerman and Aurell Taussig and senior associates Niall Crean and James Tryfonos advising on UK tax and incentives matters, partner Marina Reason and associate Ioannis Asimakopoulos on financial services regulatory matters, and associates Cassie Ayre and Jhanelle Bisasor on corporate matters.
Tom O'Neill commented: "We are very pleased to have supported Marex on its various transformational transactions including its successful US initial public offering. Well done to the Marex team and wishing you much success as a public company."
Mike Flockhart added: "Industry professionals are closely monitoring how IPO activity plays out this year - we are delighted to be advising Marex as it enters this market."
For further information on this news article, please contact:
Communications Manager
London
Herbert Smith Freehills is pleased to have advised The Ardonagh Group, the independent insurance distribution business backed by Madison Dearborn …
Corporate treasury continues to become ever more adept at responding to unpredictable macro-economic and political events, taking pre-emptive steps …
Herbert Smith Freehills’ Venture Capital team has advised Brainfish on its A$3.85 million Series Seed capital raise.
We’ll send you the latest insights and briefings tailored to your needs